Sci-Tech News Today
SEE OTHER BRANDS

The latest news on science and technology

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on August 26, 2025

Louis Bélanger-Martin Taps Australian Market for High-Impact Aviation Tech Pilots

Louis Bélanger-Martin Taps Australian Market for High-Impact Aviation Tech Pilots

Photo Courtesy of: Louis Bélanger-Martin SYDNEY, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Louis Bélanger-Martin, a longtime figure in aviation technology, is focusing his next phase of development on Australia. The Canadian entrepreneur, known for co-founding DTI …

Sana Biotechnology to Present at September 2025 Investor Conferences

Sana Biotechnology to Present at September 2025 Investor Conferences

SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in …

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming Morgan Stanley 23rd Annual …

Lesaka to Host Webcast and Conference Call to Review Fourth Quarter and Year-End 2025 Results on September 11, 2025

Lesaka to Host Webcast and Conference Call to Review Fourth Quarter and Year-End 2025 Results on September 11, 2025

JOHANNESBURG, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (NASDAQ:LSAK, JSE: LSK) ("Lesaka") now intends to release fourth quarter and year-end 2025 results after the U.S. market close on September 10, 2025. Lesaka management will host a …

Immuneering Announces Closing of $25 Million Private Placement

Immuneering Announces Closing of $25 Million Private Placement

CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced the closing of its previously announced private placement. The private …

Pulmonx to Participate in September Investor Conferences

Pulmonx to Participate in September Investor Conferences

REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that management will present at the following …

iMDx to Participate in NYC Investment Conferences September 8 - 11

iMDx to Participate in NYC Investment Conferences September 8 - 11

NASHVILLE, Tenn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced participation in investor conferences hosted by both H.C. Wainwright and Lake Street Capital Markets. Information for each can …

3D Systems Receives $7.65 Million Contract Award from U.S. Air Force for Advanced Metal Printing System

3D Systems Receives $7.65 Million Contract Award from U.S. Air Force for Advanced Metal Printing System

Two-year contract award for Large-format Metal 3D Printer Advanced Technology Demonstrator Supports development of large-scale industrial metal AM print capabilities for high-speed flight applications Award is an extension of an existing program to …

IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference

IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference

ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”) compatible patient monitoring and infusion systems, today announced that it will participate …

Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary

Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary

SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

nCino Reports Second Quarter Fiscal Year 2026 Financial Results

nCino Reports Second Quarter Fiscal Year 2026 Financial Results

Total Revenues of $148.8M, up 12% year-over-year Subscription Revenues of $130.8M, up 15% year-over-year WILMINGTON, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, …

NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

EMERYVILLE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces its Board of Directors and the Special Transaction Committee of the Board of Directors has declared a one-time …

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

MENLO PARK, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform …

Matrix Service Company Sets Date for Release of Fiscal Year 2025 Fourth Quarter and Full-Year Results and Conference Call

Matrix Service Company Sets Date for Release of Fiscal Year 2025 Fourth Quarter and Full-Year Results and Conference Call

TULSA, Okla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Matrix Service Company (Nasdaq: MTRX), a leading provider of engineering and construction services to the energy and industrial markets, announced today that it will release fourth quarter and full-year …

CompoSecure Highlights its Arculus Onchain Tap-to-Pay Capability and Showcases Innovation at Stablecoin Conference LATAM 2025

CompoSecure Highlights its Arculus Onchain Tap-to-Pay Capability and Showcases Innovation at Stablecoin Conference LATAM 2025

SOMERSET, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced it will showcase its Arculus direct onchain tap-to-pay capability and that its Head …

Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

PURCHASE, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, was notified by The Nasdaq Listing …

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

NEWTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease …

Akka and Deloitte Canada Collaborate to Deliver Agentic AI at Scale

Akka and Deloitte Canada Collaborate to Deliver Agentic AI at Scale

SAN FRANCISCO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Akka, formerly known as Lightbend and the inventors of the Akka Agentic Platform, today announced a collaboration with Deloitte Canada, in which both companies have agreed to jointly tackle the issue of …

BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025

BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025

NEW HAVEN, Conn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will host an investor …

Robotimize Unveils Comprehensive Rehabilitation Technology Showcase at AOCPRM 2025

Robotimize Unveils Comprehensive Rehabilitation Technology Showcase at AOCPRM 2025

Robotimize showcases 8 integrated rehab systems at AOCPRM 2025, uniting robotics and neurotech to scale evidence-based outcomes across Asia–Pacific. PENANG, MALAYSIA, August 26, 2025 /⁨EINPresswire.com⁩/ -- Robotimize Group, a global leader in intelligent …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions